Home/MediWound/David Tartaglia
DT

David Tartaglia

Board Member

MediWound

MediWound Pipeline

DrugIndicationPhase
NexoBridEschar removal in deep partial- and full-thickness thermal burnsApproved
EscharExDebridement of chronic and other hard-to-heal wounds (e.g., venous leg ulcers)Phase 2
MW005Treatment of non-melanoma skin cancersPre-clinical